Literature DB >> 16694726

BACTERICIDAL ACTION OF SODIUM SULFAPYRIDINE AND OF A GLUCOSE-SULFAPYRIDINE SOLUTION IN HUMAN BLOOD.

F C Lowell1, W C Spring, M Finland.   

Abstract

Entities:  

Year:  1940        PMID: 16694726      PMCID: PMC434954          DOI: 10.1172/JCI101112

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  THE RELATION OF CIRCULATING ANTIPNEUMOCOCCAL IMMUNE SUBSTANCES TO THE COURSE OF LOBAR PNEUMONIA I. NATURAL IMMUNE SUBSTANCES.

Authors:  O H Robertson; J B Graeser; L T Coggeshall; M A Harrison
Journal:  J Clin Invest       Date:  1934-07       Impact factor: 14.808

2.  IMMUNOLOGICAL STUDIES ON PATIENTS WITH PNEUMOCOCCIC PNEUMONIA TREATED WITH SULFAPYRIDINE.

Authors:  M Finland; W C Spring; F C Lowell
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

3.  STUDIES ON THE ACTION OF SULFAPYRIDINE ON PNEUMOCOCCI.

Authors:  W C Spring; F C Lowell; M Finland
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

4.  A COMPARATIVE STUDY OF THE BLOOD CONCENTRATIONS AND URINARY EXCRETION OF SULFAPYRIDINE AND SULFANILAMIDE AFTER SINGLE DOSES OF SULFAPYRIDINE AND RELATED COMPOUNDS ADMINISTERED BY VARIOUS ROUTES.

Authors:  F H Taylor; F C Lowell; M A Adams; W C Spring; M Finland; N E Marean
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

5.  THE DETERMINATION OF SULFANILAMIDE.

Authors:  E K Marshall; J T Litchfield
Journal:  Science       Date:  1938-07-22       Impact factor: 47.728

  5 in total
  2 in total

1.  IMMUNOLOGICAL STUDIES ON PATIENTS WITH PNEUMOCOCCIC PNEUMONIA TREATED WITH SULFAPYRIDINE.

Authors:  M Finland; W C Spring; F C Lowell
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

2.  A COMPARATIVE STUDY OF THE BLOOD CONCENTRATIONS AND URINARY EXCRETION OF SULFAPYRIDINE AND SULFANILAMIDE AFTER SINGLE DOSES OF SULFAPYRIDINE AND RELATED COMPOUNDS ADMINISTERED BY VARIOUS ROUTES.

Authors:  F H Taylor; F C Lowell; M A Adams; W C Spring; M Finland; N E Marean
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.